Management of MDR and XDR TB

Saved in:

Bibliographic Details
Other Authors:	Boeree, Martin (Speaker)
Format:	Electronic Video
Language:	English
Published:	London : Henry Stewart Talks, 2014.
Series:	Henry Stewart talks. Biomedical & life sciences collection. Respiratory infection.
Subjects:	Antitubercular agents. International cooperation. Multidrug-resistant tuberculosis. Tuberculosis > Chemotherapy. Tuberculosis > Prevention. Antitubercular Agents > pharmacology. Extensively Drug-Resistant Tuberculosis > drug therapy. Extensively Drug-Resistant Tuberculosis > prevention & control. International Cooperation. Tuberculosis > drug therapy. Tuberculosis > history. Tuberculosis > prevention & control. Tuberculosis, Multidrug-Resistant > drug therapy. Tuberculosis, Multidrug-Resistant > prevention & control.
Online Access:	https://hstalks.com/bs/2809/ Series
Tags:	Add Tag No Tags, Be the first to tag this record!

Table of Contents:

Contents: Management of multi drug resistance (MDR) and extensive drug resistance (XDR) TB
Management of TB before era of drug treatment
Surgery for TB
Drug treatment was introduced from 1943-1963
Rifampicin (1963)
Timeline: discovery of drugs for TB
Emergence of totally drug resistant TB
Epidemiology
Outcomes of MDR-TB treatment
Survival curve of HIV patients with XDR TB
Current drug treatment
Treatment outcome in several cohorts
Death rates in several cohorts
Current approach for treatment of MDR/XDR TB
WHO's programmatic management of DR TB
Treatment recommendations
Group 1: oral first-line agents
Group 2: fluoroquinolones
Group 3: injectables
Group 4: less-effective anti-TB drugs
Group 5: less-effective or clinical data sparse drugs
Future drug treatment
New compounds
Bedaquiline (TMC207)
The nitroimidazoles
Thioridazine
NC-001 (PA-824, moxifloxacine, PZA)
Dreams and realities for the future of TB treatment.

Similar Items